TABLE 1.
Treatment Group
|
|||
---|---|---|---|
Group A (Low Dose) (n = 6) | Group B (High Dose) (n = 6) | Total (N = 12) | |
Age, yr | |||
Mean (SD) | 42.7 (9.81) | 34.0 (9.14) | 38.3 (10.11) |
Median (minimum, maximum) | 46.0 (24, 52) | 33.5 (22, 50) | 38.0 (22, 52) |
Gender, n (%) | |||
Male | 0 (0) | 3 (50.0) | 3 (25.0) |
Female | 6 (100) | 3 (50.0) | 9 (75.0) |
Race, n (%) | |||
Black or African | 0 (0) | 1 (16.7) | 1 (8.3) |
American White | 6 (100) | 5 (83.3) | 11 (91.7) |
Ethnicity, n (%) | |||
Hispanic or Latino | 1 (16.7) | 0 (0) | 1 (8.3) |
Not Hispanic or Latino | 5 (83.3) | 6 (100) | 11 (91.7) |
Baseline CDAI score | |||
Mean (minimum, maximum) | 304.8 (234, 380) | 363.5 (253, 485) | 334.2 (234,485) |
Baseline CRP | |||
Mean (SD) | 8 (4.9) | 49 (42.1) | 28 (35.4) |
Baseline IBDQ Score | |||
Mean (minimum, maximum) | 130.0 (106, 157) | 118.7 (91, 166) | 124.3 (91, 166) |